Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Oral Leukoplakia
NCT00004161Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 1997
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in oral leukoplakia, sponsored by University of Alabama at Birmingham. Started Jun 1997; status: completed.
02
Drugs
fenretinide
03
Conditions
oral leukoplakia
Beyond the preview
Go deeper on NCT00004161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004161.